Sustainability is an important enabler of Lundbeck’s strategy, Expand and Invest to Grow. Actions to mitigate climate change will continue to permeate through all Lundbeck activities in the future.
- The climate target requires that Lundbeck’s partners and suppliers reduce their carbon footprint by at least one fifth by 2034.
- The new science based 15-year climate target, includes a detailed action plan to reduce emissions, approved by the Science Based Targets initiative (SBTi).
- As part of the target, Lundbeck also commits to becoming carbon neutral across the entire value chain no later than 2050.
Since 2006, Lundbeck has reduced its CO2-emissions by more than 70 percent and reached its first science-based target four years ahead of plan.
“Taking action to reduce climate impact is essential for ethical and sustainable business today, and we are proud to be a front runner in this area. Lundbeck supplies medicines to millions of people every day, we operate in more than 50 countries, and have multiple production and research locations in the world. Over the coming years, we will be taking even more meaningful steps, together with our supply chain partners, to ensure we can reach our goal of becoming climate neutral across the value chain,” says Deborah Dunsire, CEO and President of Lundbeck.
“Our long-term ambition is to be #1 in Brain Health. We believe that leadership includes demonstrating that we lead bringing positive change to the world – towards the climate and to the society in which we operate. This is vital to our mandate to operate and continue to deliver transformative medicines to help patients conquer brain diseases.” says Dunsire.
Read more in the full press release.